EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
163 hedge funds and large institutions have $509M invested in Eagle Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 72 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
31% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 72
Holders
163
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.4M | |
| 2 | +$11.1M | |
| 3 | +$5.46M | |
| 4 |
Morgan Stanley
New York
|
+$2.89M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.66M |
Top Sellers
| 1 | -$6.89M | |
| 2 | -$3.11M | |
| 3 | -$3.07M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.14M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$2.13M |